Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors
ceo-interviews FSD Pharma CEO: Share Consolidation Brings Us Closer to Listing on a Major US Exchange
FSD Pharma Second Tranche of Private Placement Closes, Total of $4.59 Million Raised at $20.10 To Date, Extends Offering
FSD Pharma Appoints Former Member of U.S. Congress to its Board of Directors, Announces Share Consolidation
Anaergia S.r.l. starting activities for additional C$25 million in Contracts for Two Projects in Spain
Anaergia S.r.l. starting activities for additional C$25 million in Contracts for Two Projects in Spain
Ovintiv to Host its 2025 Fourth Quarter and Year-End Results Conference Call and Webcast on February 24, 2026
Ovintiv to Host its 2025 Fourth Quarter and Year-End Results Conference Call and Webcast on February 24, 2026